December 23, 2016 / 10:09 PM / in 7 months

BRIEF-Highbridge Capital Management reports 5.3 pct passive stake in Protalix Biotherapeutics

1 Min Read

Dec 23 (Reuters) - Protalix Biotherapeutics Inc :

* Highbridge Capital Management Reports 5.3 Pct passive stake in Protalix Biotherapeutics Inc as of Dec. 13 Source text: (bit.ly/2ioIPpE) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below